FDA Inspection
California Center for Reproductive HealthCalifornia Center for Reproductive Health – FDA Inspection, Jul 15, 2024
Record Details
This FDA Inspection record concerns California Center for Reproductive Health, with an inspection on July 15, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 92b012be-1d4b-46ff-827d-ab0a87e91253
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1243852
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of California Center for Reproductive Health
4| Date | Classification | Office | Project area |
|---|---|---|---|
| August 9, 2023 | Not classified | Los Angeles District Office | |
| July 12, 2018 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 7, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 17, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for California Center for Reproductive Health
- FDA Inspection 1214495 - 2023-08-09
- FDA Inspection 1058641 - 2018-07-12
- FDA Inspection 972639 - 2016-06-07
- FDA Inspection 769379 - 2012-02-17
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.